2013-02-05
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| COMMENT | $33.840 | CAUTIOUS | NORTH AMERICAN - LARGE | Unknown |
(Market Call Minute.) There is a spinoff coming on a restructuring, so be careful about tax implications. When it spins off, buy the medical device manufacturer.
John O'Connell, CFA
Chairman and CEO,
Davis Rea